Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Cancer

Explore clinical trials studying Non-Muscle Invasive Bladder Cancer. Study availability and eligibility vary by location and protocol.

38 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Cancer trial results

Recruiting

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

NCT07206225

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • UAB Infusion Therapy Extended Care Clinic (ECC) Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Investigation Drug Services Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 68 locations
View Trial Details
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

NCT06637423

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Michael G Oefelein Clinical Trials ( Site 0053) Bakersfield, California, United States
  • Moffitt Cancer Center ( Site 0057) Tampa, Florida, United States
  • Northwestern University ( Site 0051) Chicago, Illinois, United States
  • Johns Hopkins University ( Site 0055) Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

NCT05951179

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • East Valley Urology Center of Arizona Queen Creek, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 71 locations
View Trial Details
Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

NCT07144319

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Oslo University Hospital Oslo, Norway
View Trial Details
Recruiting

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT06929286

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Johns Hopkins University (Data Collection Only) Baltimore, Maryland, United States
  • Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
View Trial Details
Recruiting

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

NCT05126472

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

NCT06503614

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Weill Cornell Medical Center New York, United States
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

NCT06245603

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Humanitas Gavezzeni-Bergamo Bergamo, Italy
  • Ospedale Sant'Orsola - Malpighi Bologna, Italy
  • Policlinico Ospedali Riuniti - Foggia Foggia, Italy
  • Istituto Oncologico Veneto IRCCS Padova, Italy
View Trial Details
Recruiting

A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer

NCT05327647

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • London Health Sciences Centre London, Ontario, Canada
  • University Health Network, Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Centre intégré de santé et services sociaux de Chaudière Appalaches Lévis, Quebec, Canada
  • Centre Hospitalier de l'Université De Montréal_CHUM Montreal, Quebec, Canada
View Trial Details

Related conditions